Table 4.
Kaposi’s sarcoma series reported in the literature evaluating clinicoepidemiological variants of the disease
| Study/Country/Year | Patient number/study period | Classic KS (%) | Iatrogenic KS (%) | Epidemic KS (%) | Endemic KS (%) |
|---|---|---|---|---|---|
| Weissmann et al./Israel/2000[3]* | 125/1957-1993 | 108 (86.4) | 17 (13.6) | * | - |
| Senturk et al./Turkey/2001[4]* | 28/1987-1997 | 19 (67.8) | 9 (32.2) | * | - |
| Dogan et al./Turkey/2010[5] | 51/1998-2009 | 50 (98.03) | - | 1 (1.9) | - |
| Jakob et al./Germany/2011[6]* | 20/1987-2009 | 15 (75) | 5 (25) | * | - |
| Tiussi et al./Brazil/2012[7] | 15/1986-2009 | 3 (20) | - | 12 (80) | - |
| Zaraa et al./Tunis/2012[8] | 75/1982-2007 | 70 (93.3) | 1 (1.3) | 4 (5.3) | - |
| Wu et al./China/2014[9]† | 105/1997-2013 | 77 (73.3) | † | 28 (26.7) | - |
| Rescigno et al./Italy/2013[10]* | 32/2008-2012 | 27 (84.3) | 5 (15.7) | * | - |
| Laresche et al./France/2014[11] | 57/1977-2009 | 17 (30) | 5 (9) | 35 (61) | - |
| Kamyab et al./Iran/2014[12] | 34/2006-2011 | 29 (85) | 5 (15) | - | - |
| Sen et al./Turkey/2016[13]* | 128/1997-2014 | 113 (88.3) | 15 (11.7) | * | - |
| Present study/Turkey/2018 | 137/2007-2017 | 88 (64.2) | 37 (27) | 11 (8.03) | 1 (0.73) |
*Non-AIDS-associated KS cases included only, †Iatrogenic KS cases excluded. KS: Kaposi’s sarcoma